Welcome to our dedicated page for Smartkem SEC filings (Ticker: SMTK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
SmartKem, Inc. (NASDAQ: SMTK) files reports with the U.S. Securities and Exchange Commission that provide detailed information on its organic semiconductor business, financial condition, capital structure and strategic initiatives. On this page, investors can review SMTK’s 8-K current reports, quarterly and annual filings, and other disclosures, with AI-powered tools that summarize key points and explain complex sections.
Recent Form 8-K filings describe several material events, including a non-binding Letter of Intent with Jericho Energy Ventures for a proposed all-stock business combination to create a U.S.-owned AI-focused infrastructure company, amendments to prior financing agreements, and a securities purchase agreement for senior secured notes and warrants that are secured by substantially all of the company’s assets. Other 8-Ks discuss equity awards to executives and directors, a Nasdaq notice regarding non-compliance with minimum stockholders’ equity requirements, the company’s decision to consider strategic alternatives, and a press release announcing a preliminary joint development agreement with Manz Asia.
SmartKem’s filings also include current reports on financial results, such as the press release for its quarter ended September 30, 2025, where it notes revenue from sales of OTFT backplanes and TRUFLEX materials for customer assessment and development purposes, as well as operating expenses and net loss figures. Additional disclosures explain that the company has curtailed operations and delayed vendor payments due to capital constraints and will require significant additional capital to resume normal operations.
Through this SEC filings page, users can access SmartKem’s 10-Q and 10-K reports (when available), proxy and governance documents, and Form 4 insider transaction reports. AI-generated summaries help highlight topics such as revenue sources, R&D spending on TRUFLEX and OTFT technologies, Nasdaq listing compliance, debt and warrant terms, and the status of the proposed Jericho transaction, allowing readers to review SMTK’s regulatory disclosures more efficiently.
Insider option grant reported for SmartKem, Inc. (SMTK). Director Melisa Denis was granted a stock option to buy 22,466 shares of common stock at an exercise price of $1.16 per share, with a transaction date of 09/03/2025 and an expiration date of 09/03/2035. The option vests 25% on the grant date and the remaining shares vest in equal monthly installments over 36 months beginning 09/03/2025. The reporting was filed on 09/05/2025 and signed by an attorney-in-fact.
SmartKem, Inc. director Klaas de Boer was granted a stock option on 09/03/2025 for 22,466 shares with an exercise price of $1.16. The option vests 25% on the grant date with the remaining shares vesting in equal monthly installments over 36 months commencing on 09/03/2025. The option appears to expire on 09/03/2035. The Form 4 was filed by an attorney-in-fact, Ian Jenks, on 09/05/2025. The reporting person is identified as a director and the filing is made by one reporting person.
SmartKem, Inc. (SMTK) Form 4 shows Ian Jenks, Chairman & CEO and Director, was granted a stock option on 09/03/2025 to acquire 160,005 shares of Common Stock at an exercise price of $1.16 per share. The option vests 25% on the grant date with the remaining shares vesting in equal monthly installments over 36 months beginning September 3, 2025. The option is exercisable through 09/03/2035. The Form 4 was signed by Ian Jenks on 09/05/2025.
Insider grant and holdings summary: SmartKem CFO Barbra Keck was granted a stock option on 09/03/2025 giving the right to buy 71,077 shares of common stock at an exercise price of $1.16 per share. The option is exercisable through 09/03/2035. Following the grant, Keck beneficially owns 71,077 underlying shares, held directly. The option vests 25% at grant with the remainder vesting in equal monthly installments over 36 months beginning 09/03/2025, with monthly vesting on the 3rd.
Peruvemba Sriram Krishnamurthy, a director of SmartKem, Inc. (SMTK), was granted a stock option on 09/03/2025 for the right to buy 22,466 shares of Common Stock at an exercise price of $1.16 per share. The option was acquired and is exercisable under a schedule that vests 25% on the grant date with the remaining shares vesting in equal monthly installments over 36 months beginning September 3, 2025. The option expires on September 3, 2035. Following the reported transaction the reporting person directly beneficially owns 22,466 option shares. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 09/05/2025.
SmartKem, Inc. reports that Nasdaq has notified the company it is not meeting the Nasdaq Capital Market’s minimum stockholders’ equity requirement. The notice cites a stockholders’ deficit of
The company’s shares remain listed on Nasdaq for now while it works to regain compliance. SmartKem has until
SmartKem ownership disclosure: Bleichroeder LP, Bleichroeder Holdings LLC and Andrew Gundlach report beneficial ownership of 231,666 common shares of SmartKem, representing 5.04% of the class. The filing shows the reporting parties hold sole voting and sole dispositive power over those shares and report no shared voting or dispositive power.
The filing notes that Bleichroeder LP is an investment adviser acting for various clients who retain the right to receive dividends or sale proceeds. The statement includes a certification that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.
Form 8-K filing dated 9 July 2025 reports a single material event under Item 8.01. SmartKem, Inc. (Nasdaq: SMTK) states that it has signed a preliminary joint development agreement with Manz Asia. No financial terms, timelines, or performance commitments are disclosed in the filing.
The company furnished Exhibit 99.1, a press release announcing the agreement, and an iXBRL cover page file (Exhibit 104). There are no accompanying financial statements, guidance changes, or pro-forma data; the report is informational only.
The filing confirms SmartKem remains an emerging growth company and maintains its listing of common shares (symbol SMTK) on The Nasdaq Stock Market. All other sections—Items 1 through 7—are omitted, indicating no additional material developments.
FAQ
What is the current stock price of Smartkem (SMTK)?
What is the market cap of Smartkem (SMTK)?
